These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1458918)

  • 21. Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
    Chen J; Ding L; Meng W; Yang J; Yan C; Xie J; Jing L; Li X; Fu Z
    Med Sci Monit; 2015 Feb; 21():505-10. PubMed ID: 25683262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.
    Boumpas DT; Austin HA; Vaughan EM; Yarboro CH; Klippel JH; Balow JE
    Ann Intern Med; 1993 Sep; 119(5):366-9. PubMed ID: 8338289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
    Steinberg AD; Steinberg SC
    Arthritis Rheum; 1991 Aug; 34(8):945-50. PubMed ID: 1859488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatoid nodules in systemic lupus erythematosus: a case report.
    Hassikou H; Le Guilchard F; Lespessailles E; Benhamou CL; Martin L; Kerdraon R
    Joint Bone Spine; 2003 Jun; 70(3):234-5. PubMed ID: 12814768
    [No Abstract]   [Full Text] [Related]  

  • 25. Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
    Schroeder JO; Euler HH; Löffler H
    Ann Intern Med; 1987 Sep; 107(3):344-6. PubMed ID: 3619224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monthly intravenous cyclophosphamide in the treatment of severe systemic lupus erythematosus.
    Sessoms SL; Kovarsky J
    Clin Exp Rheumatol; 1984; 2(3):247-51. PubMed ID: 6529878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
    Amano H; Morimoto S; Kaneko H; Tokano Y; Takasaki Y; Hashimoto H
    Lupus; 2000; 9(1):26-32. PubMed ID: 10713644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of panhypogammaglobulinaemia in a patient with systemic lupus erythematosus.
    Peral V; Vidau P; Herrera J; Rodriguez C; Tricas L; Tomé R; Arroyo F
    Nephrol Dial Transplant; 1994; 9(6):709-12. PubMed ID: 7970101
    [No Abstract]   [Full Text] [Related]  

  • 31. [The efficacy of cyclophosphamide bolus therapy in a girl with SLE with a nephritic onset].
    Ballati G; Tucciarone L; Diamanti A; Frangella E; Chiaramida N
    Minerva Pediatr; 1991 Sep; 43(9):573-6. PubMed ID: 1758394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of severe systemic lupus erythematosus].
    Schmidt RE; Witte T; Deicher H; Neumann KH; Schaumann D; Koch KM
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1891-3. PubMed ID: 1743102
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.
    Mok CC; Lau CS; Wong RW
    Am J Med; 2003 Jul; 115(1):59-62. PubMed ID: 12867236
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclophosphamide: new approaches for systemic lupus erythematosus.
    Petri M
    Lupus; 2004; 13(5):366-71. PubMed ID: 15230294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunomodulating effects of synchronised plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus.
    Hanly JG; Hong C; Zayed E; Jones JV; Jones E
    Lupus; 1995 Dec; 4(6):457-63. PubMed ID: 8749568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy.
    Suzuki K; Tanaka H; Tsugawa K; Ito E
    Tohoku J Exp Med; 2006 Apr; 208(4):355-9. PubMed ID: 16565599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide.
    Gonzalez-Crespo MR; Gomez-Reino JJ; Merino R; Ciruelo E; Gomez-Reino FJ; Muley R; Garcia-Consuegra J; Pinillos V; Rodriguez-Valverde V
    Br J Rheumatol; 1995 Aug; 34(8):737-41. PubMed ID: 7551658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of lupus nephropathy.
    Donadio JV
    Contrib Nephrol; 1985; 45():200-2. PubMed ID: 3884260
    [No Abstract]   [Full Text] [Related]  

  • 40. Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
    Dawisha SM; Yarboro CH; Vaughan EM; Austin HA; Balow JE; Klippel JH
    J Rheumatol; 1996 Feb; 23(2):273-8. PubMed ID: 8882031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.